Lower-Limb Amputees With Comorbidities Shown To Benefit From Prosthetic Intervention
Researchers have concluded the second part of their Mobility Analysis of Amputees (MAAT II) study on lower-limb amputees. The study investigated the impact of those comorbidities comprising the Functional Comorbidities Index (FCI) and other notable comorbidities, and their influence on mobility among people living with lower limb loss.
What is a Comorbidity? A comorbidity is the simultaneous presence of two chronic diseases or conditions in a patient. Some comorbidity examples are Peripheral Vascular Disease (PVD), diabetes, stroke (CVA), seizures and Post Traumatic Stress Disorder (PTSD).
MAAT II findings demonstrated a persons overall comorbid health has little impact on mobility with a lower-limb prosthesis, as patients with multiple comorbidities benefit from a prosthesis that provides meaningful mobility, according to the reserachers. The continued rise in lower-limb amputations is creating a need for improved means of identifying patients who will benefit from prosthetic rehabilitation and technology.
The MAAT II study concluded the presence of comorbidities does not preclude meaningful mobility. The outcomes from the MAAT II study will be published in an upcoming edition of America Journal of Physical Medicine and rehabilitation. Study performed by Hanger Inc.